BR0208791A - Inibidores de resistência multidroga de alcalóide de tropano de erythroxylum pervillei e uso dos mesmos - Google Patents

Inibidores de resistência multidroga de alcalóide de tropano de erythroxylum pervillei e uso dos mesmos

Info

Publication number
BR0208791A
BR0208791A BR0208791-0A BR0208791A BR0208791A BR 0208791 A BR0208791 A BR 0208791A BR 0208791 A BR0208791 A BR 0208791A BR 0208791 A BR0208791 A BR 0208791A
Authority
BR
Brazil
Prior art keywords
erythroxylum
pervillei
multidrug resistance
tropane alkaloid
resistance inhibitors
Prior art date
Application number
BR0208791-0A
Other languages
English (en)
Inventor
A Douglas Kinghorn
John M Pezzuto
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of BR0208791A publication Critical patent/BR0208791A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"INIBIDORES DE RESISTêNCIA MULTIDROGA DE ALCALóIDE DE TROPANO DE ERYTHROXYLUM PERVILLEI E USO DOS MESMOS". São revelados compostos e métodos de modulação da atividade de P-glicoproteínas. O método utiliza compostos derivados de Erythroxylum pervillei. Os compostos sobrepujam a resistência multidroga e podem ser usados terapeuticamente para melhorar a performance de drogas terapêuticas, como droga quimioterápica e antibióticos.
BR0208791-0A 2001-04-12 2002-04-11 Inibidores de resistência multidroga de alcalóide de tropano de erythroxylum pervillei e uso dos mesmos BR0208791A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28339401P 2001-04-12 2001-04-12
PCT/US2002/011358 WO2002083669A1 (en) 2001-04-12 2002-04-11 Tropane alkaloid multidrug resistance inhibitors from erythroxylum pervillei and use of the same

Publications (1)

Publication Number Publication Date
BR0208791A true BR0208791A (pt) 2004-03-09

Family

ID=23085851

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208791-0A BR0208791A (pt) 2001-04-12 2002-04-11 Inibidores de resistência multidroga de alcalóide de tropano de erythroxylum pervillei e uso dos mesmos

Country Status (7)

Country Link
US (1) US6989396B2 (pt)
EP (1) EP1392685A1 (pt)
JP (1) JP2004526766A (pt)
BR (1) BR0208791A (pt)
CA (1) CA2443655A1 (pt)
MX (1) MXPA03009307A (pt)
WO (1) WO2002083669A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012566A (es) * 2004-04-30 2007-05-09 Bkg Pharma Aps Tratamiento de enfermedades infecciosas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852033A (en) 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
US5756475A (en) 1996-01-31 1998-05-26 Nisshin Flour Milling Co., Ltd. Isoprene derivatives

Also Published As

Publication number Publication date
JP2004526766A (ja) 2004-09-02
MXPA03009307A (es) 2004-12-03
WO2002083669A1 (en) 2002-10-24
EP1392685A1 (en) 2004-03-03
US6989396B2 (en) 2006-01-24
US20030092729A1 (en) 2003-05-15
CA2443655A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
WO2003087094A3 (en) Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
RS50031B (sr) Triciklični inhibitori poli(adp-riboza)polimeraza
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
DK0879820T3 (da) Benzamidanaloger anvendelige som PARP (ADP-Ribosyltransferase, ADPRT) DNA-reparations enzyminhibitorer
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
HUP9903741A2 (hu) Asztmaellenes, allergiaellenes, immunvisszaszorító és/vagy immunmoduláló hatású N-helyettesített indol-3-glioxilamidok
DK1017692T3 (da) 4-Heteroaryl-tetrahydroquinoliner og deres anvendelse som inhibitorer af cholesterolester-transferproteiner
BR0110521A (pt) Carbamatos azabicìclicos e seu uso como agonistas de receptores de alfa-7 acetilcolina nicotìnico
AU4327600A (en) Aryl sulfonyls as factor xa inhibitors
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
MY130803A (en) New quinuclidine amide derivatives
MA28366A1 (fr) Derives de piperidinylalkylcarbamates, leur preparation et leur application comme inhibiteurs de l&#39;enzyme faah
WO2004000840A3 (en) Quinuclidine derivatives and pharmaceutical compositions containing the same
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
BR0007864A (pt) Composto, e, uso de um composto
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
DE60009888D1 (de) Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
BRPI0507987A (pt) métodos e compostos moduladores receptor de glicocorticóide
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired